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TRABECTOME 
TECHNIQUE + POSTOP CARE 
MIGS vs Trabs/Tubes? 
Trabectome Technique + Postop Care 
 
Overview 
MINIMALLY INVASIVE GLAUCOMA 
SURGERIES (MIGS) VS TRABS/TUBES 
Problems with Hardware and MMC 
up to 
9% 
MIGS 
*Rosenquist et al. Curr Eye Res PMID: 2627793 
240° versus 60° 
Single access point devices: 
- achieve only 2 clock hours of outflow segment access.  
Canalography courtesy of UPMC’s 
Glaucoma Imaging Group 
Outflow Tract Anatomy 
sagittal view 
frontal view 
schematic 
view 
Trabectome Surgical System 
new, tapered sleeve 
Plasma Surgery: Bipolar 550 kHz Ablation 
of Trabecular Meshwork 
● selective removal of primary pathology 
● 200 micron plasma, pico-lightning 
● no heat transfer, protective footplate 
1.2o  C 
Very hot 
Very short (1ms) 
Low duty cycle 
continuous 
aspiration 
Location of Collector Orifices 
courtesy of Doug Johnson 
proximity to anterior and posterior lips may explain high 
failure rate of goniotomy in adults 
Challenges with Microstents 
Fibrosis + Compression of Collector Channels 
courtesy of Ivantis Inc., Irvine, CA 
Angle Surgery: What Glaucomas? 
POAG 
Pseudoexfoliation 
Steroid induced 
Anti-VEGF agents-induced 
Acute angle closure 
Chronic angle closure 
Low pressure 30% 
TM
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Success 
90-70% 
Working collector drainage system necessary. 
Currently no function test available. 
 
5 Year Complications 
MIGS  
● early 10 mmHg IOP 
elevation that resolves 
o trabectome: 3-10% 
 
● hyphema that resolves 
o more Schlemm's canal 
access = more hyphema 
o trabectome > hydrus > 
iStent 
Trab/Tube (TVT Study) 
● "manipulation needed" 
o trabs: 74% 
o tubes: 27%  
● early + late, vision 
threatening 
o trabs: 39 + 38 = 77% 
o tubes: 22 + 36 = 58% 
Cost Effective Treatment Algorithm 
*Iordanous Y et al. J Glaucoma. 2013.  
BAT 20/50, 
wants to improve vision, 
has OHTN to advanced glaucoma 
 
CEIOL + trabectome 
toric lens 
 
bypass surgery 
(tube, trab, suprachoroidal devices) 
SLT 
 
PGAs + CAIs 
TRABECTOME 
TECHNIQUE + POSTOP CARE 
Key Surgical Steps 
1.Visualization 
- excellent microscope (xenon, large tilt) 
- no visco at start 
- hypotony, identify 
1.Technique 
- anterior, flared incision 
- no outward push 
- near 180o ablation 
1.Reducing hyphema 
- viscoelastic tamponade: after ablation + after phaco 
- pressurize well 
 
 

VISUALIZATION 
Large Tilt, Xenon Light 
Impact of Microscope Quality 
● high end, xenon light 
● large tilt 
● insufficient tilt: requires 
patient rotation 
● yellow light: hard to see lacy 
tissue 
✓ STOP 
No Viscoelastic Prior to Trabectome 
Because viscoelastic: 
● traps plasma gas bubbles 
● creates blurr from density interfaces 
● makes it harder to induce hypotony 
to identify Schlemm's canal 
SURGICAL STEPS 
2 mm Anterior, Flared Incision 
● extend reach, no striae 
● prevent iris prolapse 
Induce Hypotony to Identify TM 
gape incision  
SC 
tip parallel 
hard to engage 
pointed at TM 
easy to engage 
Easier Engagement Towards Left 
Engaging the TM 
1. just anterior 
to spur:  
engage 
pointing up 
2. advance 
strictly parallel, 
no outward push 
TM removal: careful 
with outward push as if 
you were peeling an 
epiretinal membrane 
Engaging the TM 
180o Ablation 
90o ablation 90o ablation 
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Larger Arc = More Collectors 
● Marginally significant correlation between: 
o Ablation arc size vs final IOP (P=0.06) 
o Ablation arc size vs final number of medications 
(P=0.07) 
IOP = 20.5 - 0.053(Arc size) 
n=29; R=0.351; P=0.06 
A. Sit, 2011 
After Trabectome 
1. Tamponade trabectome ablation with DisCoVisc 
2. Enlarge same incision with keratome heel down 
(self sealing) 
3. Phaco 
4. Tamponade ablation  
     again with DisCoVisc 
5. IOL (+ CTR for torics if phacodonesis) 
6. Leave visco in distal  
    half of AC (no hyphema) 
up to 30% 
AC filling 
Incision Enlargement  for CEIOL 
Post-Op 
● "Changing blurriness for days“,  
blurry = outflow system present! 
● POV 1 day, 1 week, month 1, 2, 3 
o Pilo QID x 1 month, TID 1 month, BID 1 month 
o Pred Forte QID tapered one drop per week 
o discontinue some glaucoma drops 
Summary: Key Surgical Steps 
1. Visualization 
- excellent microscope (xenon, large tilt) 
- no visco at start 
- hypotony, identify 
2. Technique 
- anterior, flared incision 
- no outward push 
- near 180o ablation 
3. Reducing hyphema 
- viscoelastic tamponade: after ablation + after phaco 
- pressurize well 
 
 

First Trainee Cases 

OUTCOMES 
Global Outcomes 
Phaco-Trabectome 
  # Medications # Medications 
Baseline 2.3±1.2 2.8±1.3 
6M 1.6±1.3 2.3±1.4 
36M 1.9±1.2 (p=0.1) 2.0±1.4 (p<0.01) 
Trabectome-only 
N = 15 N = 58 N = 1873 N = 1401 
Global Outcomes 
Trabectome alone 
64.9%  
Trabectome and PCE 
86.9%  
Success definition: 
No additional glaucoma surgery and 
IOP reduction ≥20% from pre-op and IOP <21 mmHg 
last 2 follow ups, after 3 months post-op 
Trabectome-Only Results 
Authors 
 
Study Type  # of pts pre-sx IOP % decrease  meds 
decrease 
months 
Minckler 
2005 
Pro 
 
37 28 40 % 0.9 13 
Minckler, 
2006 Pro 101 28 40 % n/a 
30 
 
Minckler, 
2008 Retro 738 26 35 % 1.1 60 
Ting, 
 2012 Pro 450 26 34 % 0.6 12 
Ting,2012 Pro 67 29 44 % 0.9 12 
Jea, 2012 Retro 115 28 41 % 1 30 
Minckler, 
2012 Retro 1151 26 36 % 1.7 60 
Mosaed, 
2011 Retro 538 26 31 % 0.8 12   
Phaco-Trabectome Results 
Authors 
 
Study Type  # of pts pre-sx IOP % decrease  meds 
decrease 
months 
Minckler 
2008 retro 366 20 20 % 1.2 60 
Francis, 2008 Pro 304 20 25 % 1.2 21 
Francis, 2011 Pro 89 22 27 % 1 12 
Ting, 
 2012 Pro 263 20 22 % 0.7 12 
Ting,2012 Pro 45 22 35 % 0.9 12 
Minckler, 
2011 retro 681 20 21 % 0.9 36 
Mosaed, 
2011 retro 290 20 18 % 0.8 12 
Kaplowitz, 
Loewen * retro 192 20 28 % 0.8 24 
* including ACG, NVG, uveitic, secondary procedures   
6 Year Outcomes 
IOP (mmHg) 
Glaucoma Medication Use 
n = 3445 
Trabectome vs. Trabeculectomy  
(Dr. Brian Francis) 
N = 58 
Major complications: Trabectome-phaco group  including subsequent 
trabeculectomy  & tube = 4 
Major complications: Trabeculectomy-phaco group  including repeat 
trabeculectomy & tube  = 16 
Brian A. Francis; Jonathan Winarko; Clinical & Surgical Ophthalmology 29:2/3, 2011 
N = 89  = 23 
N = 58 
Trabectome vs. Trabeculectomy 
(Brian Francis) 
Trabectome AFTER Trabeculectomy 
 
Bussel II, Kaplowitz K, Schuman JS, Loewen NA 
 Outcomes of ab interno trabeculectomy with the trabectome after 
failed trabeculectomy. 
Br J Ophthalmol. 2014 Aug 28. 
 
 
 
Trabectome AFTER Trabeculectomy 
Phaco-Trabectome 
  # Medications # Medications 
Baseline 2.5±1.5 2.8±1.2 
6M 1.8±1.5 2±1.3 
12M 1.6±1.4 (p=0.1) 2±1.3 (p<0.01) 
Trabectome-only 
N = 15 N = 58 
Bussel, II et al. BJO (2014) 
Trabectome by  
Degree of Angle Opening 
Bussel II, Kaplowitz K, Schuman JS, Loewen NA 
Outcomes of ab interno trabeculectomy with the trabectome by degree of 
angle opening. 
Br J Ophthalmol. 2014 Oct 21. 
 
 
 
 
N = 15 
Trabectome by Degree of Angle Opening 
N = 15 
Trabectome by Degree of Angle Opening 
N = 15 
Trabectome Matched to Ahmed Valves 
N=32 per group 
* 
T, A: 3 drops T: 1.9 drops 
A: 4.1 drops 
Outcome by Type of Glaucoma 
POAG + Pseudoexfoliation 
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N=2828 
Uveitic + Steroid Glaucoma 
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N=69 
N=49 
Infantile Glaucoma 
Phaco-Trabectome Trabectome only 
N=18 N=10 
Highly Complex, Mixed Mechanism Glaucomas 
Trabectome with glued, tied Baerveldt 
Wet Lab 
WET LAB 
 
 Skills Transfer  Course 
 Wet Lab Introduction 
Brian Francis MD, MS 
Associate Professor of Ophthalmology 
Doheny-USC, Los Angeles, California 
  
Trabectome Surgical System 
  
Unique Key Features 
  
Human Corneal-Scleral Rim Setup 
  
Human Corneal-Scleral Rim Setup 
  
Handpiece Grip Technique 
  
Trabecular Meshwork Removal 
  George Baerveldt, MD, University of California, Irvine 
CASE PRESENTATIONS 
Case Representations 
● Sjogren + Steroids 
● Corneal Synechiae, Angle Closure 
● Pseudoexfoliation 
 
Historical Cases 
● phaco-trabectome in POAG 
● phaco-trabectome in PXG 
 
 
Overview 
CASE 1:  
SJOGREN + STEROID GLC 
●73-year-old Caucasian woman 
●35 mmHg on 3 gtts 
●Severe Sjogren’s Syndrome 
oSevere DES  
oFilamentary keratitis 
oErosions 
oXerostomia 
HPI 
●Prednisone 4 mg QD, KCl 20 mEq 
QD, Alendronate, Calcium with 
vitamin D 
●Steroid-induced glaucoma OU  
o50 mmHg max 
oUnnoticed by PMD x 6 months 
HPI 
Exam 
OD OS 
VA (cc) 20/50  20/200  
Lens 3+ NS, +1 PSC 
Disc 0.9 C/D 
Severe inf, 
moderate sup 
thinning 
0.95 C/D 
Severe inf + sup 
thinning 
Cornea filaments 
Lids severe crusting 

Phaco-Trabectome 
OD  
●POD #1: VA 20/25-2, IOP 10.  
●POM #12: VA 20/25+, IOP 12. No gtts 
for IOP 
 
OS 
●POV: 10 mm Hg x 5 months  
●POM #18: 14 mm Hg (added Travatan Z) 
CASE 2:  
CORNEAL SYNECHIAE = ACG 
● 81-year-old Caucasian woman 
● Deaf mute 
● 20 mmHg on 3 gtts + oral CAI 
● DSAEK OS years ago 
○ 180 corneal-iris touch  
○ drops affecting transplant 
○ difficult med adherence 
HPI 
Exam 
OD OS 
VA (cc) 20/70 20/150 
Lens sulcus PCIOL 
Disc 0.4 C/D 0.7 C/D 
Inf thinning 
cornea DSAEK 
Iris 180o iridocorneal adhesions 
iridocorneal 
adhesion 
DSAEK 12  
6 
Dissection of Iridocorneal Adhesions 
12  
9 
6 
Trabectome Goniosynechiolysis 
Trabectome Ablation 
open Schlemm's 
trabectome 
Outcome 
●POM#18: OS VA 20/60, IOP 12 
●timolol QAM 
Summary 
MIGS vs Trabs/Tubes 
Trabectome Technique + Postop Care 
Outcomes 
Case Presentations 
 
Thank you. 
 
 
 
 
optional: 
COST CONTAINMENT IN 
GLAUCOMA 
COST CONTAINMENT IN 
GLAUCOMA 
Increasing Lifespan 
The Cause of Glaucoma 
Persistence with Glaucoma 
Medications 
Kass MA, 1986, AJO. Granstrom PA, 1982, BJO Reardon G, 2004, AJO 
 
Friedman et al, IOVS, 2007:  
● 59% patients had opportunity to fill gtts at 12 months after initial prescription 
● only 10% actually had medication available continuously 
●$138,000-150,000 USD/QALY 
●But: sequence of SLT, gtts, trab is very cost effective 
(instead of max gtts, SLT, trab): 
savings would return  
$2.50 for every $1.00 spent 
Costs of Glaucoma Treatment 
Taylor HR, Ophth, 2009 
 
Performing trabectome early might also keep costs 
down and improve vision (if done with CEIOL) 
